Across TCGA pan-cancer cohorts, BOD1L2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of BOD1L2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where BOD1L2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BOD1L2 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD and KIRC are the cancer types where BOD1L2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BOD1L2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.023	.001	6	view →
KIRC	Male	III,IV	−0.004	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: BOD1L2 RNA expression & survival · all BOD1L2 data types